Prospective Study Comparing Brand and Generic Immunosuppression on Transplant Outcomes, Adherence, & Immune Response in Kidney Transplant Recipients

NCT02866682 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

176

Enrollment

OTHER

Sponsor class

Conditions

Renal Transplant Rejection

Interventions

DRUG: Prograf
DRUG: Tacrolimus

Sponsor

University of California, Los Angeles

Collaborators

[object Object]